Is it necessary to operáte non-
metastatic breast cancer in the elderly?
JANDÍK P.i, MERGANCOVÁ J.1, ČEČKA F.1, MELICHAR B.2, DVOŘÁK J.2, URMÍNSKÁ H.3
1 Chirurgická klinika, přednosta prof. MUDr. Zbyněk Vobořil, DrSc. 2Klinika onkologie a radioterapie, přednosta doc. MUDr. Jiří Petera, Ph.D. 3Radiodiagnostická klinika, přednosta prof. MUDr. Pavel Eliáš, CSc. Fakultní nemocnice Hradec Králové Ředitel: doc. MUDr. Leoš Heger, CSc. |
|
Summary:
The authors presents a group of 52 patients in advanced age with non-metastatic breast cancer. In addition
to confirmed hormonally dependent carcinoma, all háve had an important co-morbidity. Therefore in all
patients, hormonal therapy (HT) by selective aromatase inhibitors was the first choice treatment. Tumor
regression was detected in 45 patients (86, 5%), a complete clinical response in 8 (15,5 %). An important
therapeutic benefit was noticed, which helped to maintain an adequate quality of life.
Key words:
breast carcinoma in the elderly, selective aromatase inhibitors, primary treatment
|
